Momenta Pharmaceuticals, Inc. announced earnings results for the fourth quarter ended December 31, 2019. For the fourth quarter, the company announced total revenue was USD 8.182 million compared to USD 42.822 million a year ago. Operating loss was USD 87.280 million compared to USD 9.670 million a year ago. Net loss was USD 86.700 million compared to USD 8.244 million a year ago. Basic loss per share was USD 0.85 compared to USD 0.1 a year ago. For the full year, total revenue was USD 23.868 million compared to USD 75.589 million a year ago. Operating loss was USD 298.091 million compared to USD 181.327 million a year ago. Net loss was USD 290.055 million compared to USD 176.061 million a year ago. Basic loss per share was USD 2.92 compared to USD 2.26 a year ago.